Funding Details
- Awarder
- Inbox
- Date Award
- April 14, 2017
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
Company Info
- Traction
- Actively enrolling patients in a Phase 2b clinical trial.
- Company Description
- Cirius Therapeutics, formerly known as Octeta Therapeutics, is a clinical-stage pharmaceutical company focused on developing therapies to treat liver disease. The company's lead product is MSDC-0602K, a second-generation insulin sensitizer for the treatment of NASH.
- Market
- Liver Disease Treatment
- Location
-
Kalamazoo,
Michigan,
USA
- Coinvestors
- Adams Street Partners, Frazier Healthcare, Novo A/S, Renaissance Venture Capital Fund
Links